Data-Driven Enterprise Architecture for Pharmaceutical R&D

Abstract

This paper addresses the research gap in the realm of data-driven transformation by leveraging the Resource-Based View (RBV) theory and the dynamic capabilities concept to the contours of a data-driven enterprise. It confronts the limitations of conventional digital and data transformation programs, which often prioritize technological enhancements over crucial organizational and cultural shifts. Proposing a more holistic perspective, the Data-Driven Enterprise Architecture Framework (DDA) is introduced, emphasizing the domain decomposition and productization of an architecture, distributed ownership, and federated governance, while ensuring the continuous harmonization of data, application, and business architecture. A case study featuring a leading pharmaceutical company illustrates the practical implementation of the DDA framework as a pillar of their Digital Transformation Strategy. By integrating scalable and distributed data architecture into the overarching Enterprise Architecture landscape, the company has initiated their data-driven transformation journey, showcased through their initial and very early results. This research not only offers valuable insights for pharmaceutical organizations navigating the complexities of data-driven transformations, but also addresses a research gap in the field.

Cite this work

No public copy is stored for this record, so only the metadata is cited.

Stored only when both papers are in the corpus — 14 citations exist upstream.

Papers that cite the same references — the relational fallback while embeddings are still backfilling.